Laura Diez-Gonzalez

Learn More
BACKGROUND Aberrations in the phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR)/AKT pathway are common in solid tumors. Numerous drugs have been developed to target different components of this pathway. However the prognostic value of these aberrations is unclear. METHODS PubMed was searched for studies evaluating the association(More)
  • 1